Corebridge Financial (CRBG) Is Up - What Are Investors Seeing in This Stock?

Corebridge Financial stock is trading -32.96% below its average target price of $25.0 after marking a 1.1% during Friday's morning session. Analysts are giving the Large-Cap Life Insurance company an average rating of buy and target prices ranging from $22.0 to $32.0 per share.

Corebridge Financial has an average level of shares sold short, at 6.3% of its total share float. The stock's short ratio (also called days to cover) is 5.41. The company's insiders own 77.72% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Institutional investors own 24.5% of Corebridge Financial's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in Corebridge Financial

Date Reported Holder Percentage Shares Value
2023-03-31 Blackstone Inc 10% 63,855,000 $1,070,209,814
2023-03-31 Price (T.Rowe) Associates Inc 3% 18,725,378 $313,837,339
2023-03-31 Vanguard Group, Inc. (The) 1% 6,930,409 $116,153,656
2023-03-31 Capital Research Global Investors 1% 6,143,519 $102,965,379
2022-12-31 Norges Bank Investment Management 1% 5,753,228 $96,424,102
2023-03-31 TD Asset Management, Inc 1% 5,022,680 $84,180,117
2023-03-31 Hotchkis & Wiley Capital Management, LLC 1% 4,854,299 $81,358,052
2023-03-31 Zimmer Partners, Lp 1% 4,553,996 $76,324,974
2023-03-31 Harris Associates L.P. 0% 2,695,305 $45,173,312
2023-03-31 FMR, LLC 0% 2,423,926 $40,625,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS